N6-Substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells
Peng Liu(Inserm), Qin Wang(Lanzhou University), Ximing Xu(Shanghai Changzheng Hospital), Jing Chen(Lanzhou University), Wenchao Zhang(Jiangnan University), Liwei Zhao(Université Paris Cité), Cheng Zhou(Second Affiliated Hospital of Zhejiang University), Yuping Du(Lanzhou University of Technology), Yanlong Pan(Southwest Jiaotong University), Jinbo Yang(Cleveland Foundation), Feng Liu(Lanzhou University)
Cited by 8
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.8k
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB
|Genes & Development|2007|610
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
|Scientific Reports|2019|426
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
|Nature Communications|2019|298